Penumbra

Through groundbreaking technology, we are revolutionizing interventional therapies at Penumbra, Inc. Founded in 2004 and headquartered in Alameda, California, Penumbra is a global healthcare company dedicated to developing and manufacturing innovative medical devices. Our primary focus is on addressing challenging medical conditions with significant unmet needs, particularly in the neurovascular and peripheral vascular markets. We design, develop, manufacture, and market a broad portfolio of novel products that support healthcare providers, hospitals, and clinics in over 100 countries. Our commitment is to improve patient outcomes and quality of life worldwide.

Penumbra is recognized as a world-leading thrombectomy company, with a strong emphasis on pioneering technologies for conditions such as ischemic stroke, venous thromboembolism (like pulmonary embolism), and acute limb ischemia. A cornerstone of our innovation is Computer Assisted Vacuum Thrombectomy (CAVT), a technology that centers on removing blood clots from head-to-toe with speed, safety, and simplicity. Our product lines include neurovascular access systems, revascularization devices, embolization coiling systems, and microcatheters. We are constantly pushing the boundaries of medical technology to develop more effective and less invasive treatments. This dedication to innovation has been a key driver of our growth, allowing us to expand our reach and help an increasing number of patients. Our team of over 4,500 employees is mission-minded and plays a crucial role in shaping the future of healthcare. We strive to make our advanced products accessible globally, transforming patient care through our relentless pursuit of innovation.